Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Churchill Capital Corp II was a NYSE‑listed special purpose acquisition company that completed its business combination with Software Luxembourg Holding (Skillsoft) and the acquisition of Albert DE Holdings (Global Knowledge) in June 2021, with the combined company renamed Skillsoft Corp. and listed on the NYSE under ticker SKIL.[2][3][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Churchill Capital Corp II.